Calyxt Inc (CLXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLXT | LTRN | RNXT | ||
| Company | Calyxt Inc | Lantern Pharma Inc | Renovorx Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 6.16 | 3.17 | 1.2200 | ||
| High | 7.77 | 3.41 | 1.2700 | ||
| Low | 6.01 | 3.10 | 1.1400 | ||
| Last | 6.30 | 3.14 | 1.2500 | ||
| Change | +0.33 | -0.07 | +0.1000 | ||
| % Change | +5.53% | -2.02% | +8.70% | ||
| Volume | 254,600 | 39,300 | 94,800 | ||
| 20-Day Average Volume | 63,345 | 77,700 | 112,225 | ||
| Previous Close | 5.97 | 3.21 | 1.1500 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 4.10 | 3.44 | 1.2825 | ||
| 20-Day Raw Stochastic | 69.38% | 16.59% | 31.25% | ||
| 20-Day Relative Strength | 75.29% | 44.47% | 52.39% | ||
| Weighted Alpha | +160.70 | -58.19 | -24.80 | ||
| Today's Opinion | 100% Buy | 72% Sell | 48% Buy | ||
| Previous Opinion | 100% Buy | 72% Sell | 16% Buy | ||
| Last Month's Opinion | 56% Buy | 100% Sell | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +28.05% since 05/23/23 | -8.71% since 12/13/24 | -2.34% since 12/13/24 | ||
| Low | 4.53 on 05/25/23 | 3.10 on 12/20/24 | 1.1000 on 12/18/24 | ||
| High | 7.77 on 05/31/23 | 3.60 on 12/18/24 | 1.3200 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | +107.92% since 04/28/23 | +6.97% since 11/20/24 | +5.04% since 11/20/24 | ||
| Low | 2.64 on 05/01/23 | 2.79 on 11/21/24 | 1.0800 on 11/21/24 | ||
| High | 7.77 on 05/31/23 | 4.88 on 12/09/24 | 1.5800 on 11/22/24 | ||
| 3-Month | |||||
| %Chg | +49.96% since 02/28/23 | -21.18% since 09/20/24 | +2.46% since 09/20/24 | ||
| Low | 2.41 on 04/12/23 | 2.79 on 11/21/24 | 0.7736 on 10/24/24 | ||
| High | 7.77 on 05/31/23 | 4.88 on 12/09/24 | 1.5800 on 11/22/24 | ||
| 6-Month | |||||
| %Chg | +303.33% since 11/28/22 | -29.17% since 06/20/24 | -3.85% since 06/20/24 | ||
| Low | 1.32 on 12/27/22 | 2.79 on 11/21/24 | 0.7736 on 10/24/24 | ||
| High | 7.77 on 05/31/23 | 5.10 on 07/18/24 | 1.5800 on 11/22/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 31,334 | 33,919 | 30,001 | ||
| Shares Outstanding, K | 4,974 | 10,785 | 24,001 | ||
| Annual Sales | 160,000 | 0 | 0 | ||
| Annual Net Income | -16,890,000 | -15,960,000 | -10,230,000 | ||
| Last Quarter Sales | 40,000 | 0 | 0 | ||
| Last Quarter Net Income | -5,390,000 | -4,510,000 | -2,470,000 | ||
| 60-Month Beta | 2.04 | 1.56 | 1.10 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.09 on 05/01/23 | -0.42 on 11/07/24 | -0.10 on 11/13/24 | ||
| Latest Earnings Date | 05/04/23 | 11/07/24 | 11/11/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||